Journal for ImmunoTherapy of Cancer shared a post on LinkedIn:
“We’re pleased to share that JITC’s 2025 Impact Factor increased to 11.7, reflecting the growing reach and citation of work published in the Journal.
This metric is one of several indicators of the Journal’s performance and engagement and places JITC among the top 5% of immunology journals and the top 9% of oncology journals in the 2025 Journal Citation Reports—a significant achievement that reflects the continued strength, influence, and growth of our journal.
Thank you to our authors, reviewers, editors, and readers for contributing to another strong year for JITC.
Interested in cutting-edge immunology research. Explore: About JITC.”
Other articles about JITC on OncoDaily.